Total Payments
$1.9M
2024 Payments
$189,399
Companies
20
Transactions
1,922
Payment Breakdown by Category
Other$1.3M (67.6%)
Travel$369,076 (19.8%)
Consulting$181,118 (9.7%)
Food & Beverage$47,827 (2.6%)
Research$4,760 (0.3%)
Education$369.26 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 467 | 67.6% |
| Travel and Lodging | $369,076 | 738 | 19.8% |
| Consulting Fee | $181,118 | 64 | 9.7% |
| Food and Beverage | $47,827 | 626 | 2.6% |
| Unspecified | $4,760 | 3 | 0.3% |
| Education | $369.26 | 24 | 0.0% |
Payments by Type
General
$1.9M
1,919 transactions
Research
$4,760
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $401,673 | 492 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $354,500 | 344 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $256,519 | 231 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $235,377 | 232 | $0 (2023) |
| Janssen Biotech, Inc. | $169,307 | 151 | $0 (2024) |
| GENZYME CORPORATION | $144,376 | 142 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83,056 | 56 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $69,695 | 65 | $0 (2024) |
| PFIZER INC. | $49,262 | 64 | $0 (2023) |
| Lilly USA, LLC | $46,381 | 61 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189,399 | 174 | Janssen Biotech, Inc. ($83,319) |
| 2023 | $251,604 | 242 | AstraZeneca Pharmaceuticals LP ($98,531) |
| 2022 | $301,637 | 298 | AstraZeneca Pharmaceuticals LP ($110,062) |
| 2021 | $118,374 | 122 | AbbVie Inc. ($50,926) |
| 2020 | $144,960 | 146 | E.R. Squibb & Sons, L.L.C. ($66,648) |
| 2019 | $316,653 | 366 | E.R. Squibb & Sons, L.L.C. ($107,852) |
| 2018 | $365,764 | 361 | Novartis Pharmaceuticals Corporation ($99,994) |
| 2017 | $174,874 | 213 | E.R. Squibb & Sons, L.L.C. ($79,367) |
All Payment Transactions
1,922 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $768.43 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $109.77 | General |
| Category: Immunology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $1,175.37 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $125.62 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Consulting Fee | Cash or cash equivalent | $6,440.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Consulting Fee | Cash or cash equivalent | $920.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $132.02 | General |
| Category: Immunology | ||||||
| 11/17/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $115.82 | General |
| Category: Immunology | ||||||
| 11/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $43.56 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $132.60 | General |
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $99.45 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $59.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.75 | General |
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $796.96 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $498.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $234.08 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,980 | 2 |
| TOFACITINIB RA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
About Dr. Frank Wellborne, D.O
Dr. Frank Wellborne, D.O is a Rheumatology healthcare provider based in New Braunfels, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780714857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Wellborne, D.O has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $189,399 received in 2024. These payments were reported across 1,922 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
Ad
Practice Information
- Specialty Rheumatology
- Location New Braunfels, TX
- Active Since 03/06/2007
- Last Updated 05/10/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780714857
Products in Payments
- ORENCIA (Biological) $328,068
- SAPHNELO (Biological) $255,860
- COSENTYX (Biological) $212,534
- RINVOQ (Biological) $183,278
- SIMPONI ARIA (Biological) $125,343
- TREMFYA (Drug) $113,599
- Humira (Biological) $102,050
- KEVZARA (Drug) $64,538
- OFEV (Drug) $62,258
- KEVZARA (Biological) $55,845
- XELJANZ (Drug) $49,171
- Rinvoq (Biological) $35,721
- RINVOQ (Drug) $34,850
- DUZALLO (Drug) $22,364
- OLUMIANT (Drug) $21,600
- NO PRODUCT DISCUSSED (Drug) $20,844
- Bimzelx (Biological) $14,289
- HUMIRA (Biological) $8,563
- KEVZARA SARILUMAB INJECTION (Biological) $6,371
- SKYRIZI (Biological) $6,364
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.